Point72 Asset Management, L.P. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 111 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$364
-100.0%
272
-100.0%
0.00%
-100.0%
Q4 2022$6,771,484
+35539.4%
1,991,613
+56803.2%
0.02%
Q3 2022$19,000
-99.6%
3,500
-99.0%
0.00%
-100.0%
Q3 2020$5,106,000
-67.2%
349,723
-86.5%
0.03%
-67.9%
Q2 2019$15,552,000
+7.7%
2,596,323
+68.4%
0.08%
+14.1%
Q4 2018$14,446,000
-10.8%
1,541,718
+62.2%
0.07%
+6.0%
Q3 2018$16,187,000
-33.9%
950,493
-34.1%
0.07%
-31.6%
Q2 2018$24,503,000
-6.8%
1,442,183
-26.4%
0.10%
-10.9%
Q1 2018$26,283,000
-18.3%
1,958,527
-41.6%
0.11%
-20.9%
Q4 2017$32,179,000
+2236.9%
3,351,996
+8407.6%
0.14%
+1290.0%
Q3 2014$1,377,000
+270.2%
39,400
+392.5%
0.01%
+400.0%
Q2 2014$372,0008,0000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,200,396$30,084,0001.72%
TFS CAPITAL LLC 105,040$987,0000.26%
Tekla Capital Management LLC 500,324$4,703,0000.20%
Piermont Capital Management Inc. 51,080$480,0000.11%
ESSEX INVESTMENT MANAGEMENT CO LLC 55,793$524,0000.09%
Candriam S.C.A. 390,000$3,666,0000.08%
Virtus ETF Advisers LLC 27,446$258,0000.08%
SECOR Capital Advisors, LP 66,484$625,0000.08%
Trexquant Investment LP 29,007$273,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 32,196$303,0000.04%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders